OR WAIT null SECS
Elaine Quilici is Pharmaceutical Executive's Senior Editor. Email her at email@example.com
Kevin Buckley, founder of Torrey Pines Law Group, and Neil Thompson, a patent agent with the firm, discuss IP strategy as it relates to pharma and artificial intelligence.
Kevin Buckley, founder of Torrey Pines Law Group, and Neil Thompson, a patent agent at the firm, talk about the increasing use of artificial intelligence in pharma and how that is affecting the realm of intellectual property.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.